2016
DOI: 10.1159/000445529
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Risk Factors and Plaque Characteristics Associated with New Development of Contralateral Stenosis in Patients Undergoing Carotid Endarterectomy

Abstract: Background: Following carotid endarterectomy (CEA), cerebrovascular hemodynamic may be hampered by ipsilateral restenosis or development of contralateral stenosis. It remains to be clarified if these patients need follow-up for identifying development of contralateral stenosis. Identification of risk factors contributing to development of contralateral stenosis could allow more specific follow-up. In this current study, we assessed clinical risk factors and plaque characteristics of patients undergoing CEA wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 23 publications
(38 reference statements)
0
3
0
Order By: Relevance
“…In addition, modified low-density lipoprotein (LDL), such as oxidized LDL (oxLDL), further induces the necrosis of foam cells, which can form a necrotic core, a typical feature of the instability of advanced plaques, leading to the rupture of plaques and further acute life-threatening clinical cardiovascular events [9]. Studies have concluded that increased lesional CD68 + macrophages are associated with a higher risk of CVD and stroke events, while presenting a weak relationship with stenosis [10, 11]. Therefore, clarifying the macrophage-dependent inflammatory processes in atherosclerosis progression and exploring macrophage-targeted strategies to reduce the residual risk of atherosclerotic CVD have become a hot research topic in recent years.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, modified low-density lipoprotein (LDL), such as oxidized LDL (oxLDL), further induces the necrosis of foam cells, which can form a necrotic core, a typical feature of the instability of advanced plaques, leading to the rupture of plaques and further acute life-threatening clinical cardiovascular events [9]. Studies have concluded that increased lesional CD68 + macrophages are associated with a higher risk of CVD and stroke events, while presenting a weak relationship with stenosis [10, 11]. Therefore, clarifying the macrophage-dependent inflammatory processes in atherosclerosis progression and exploring macrophage-targeted strategies to reduce the residual risk of atherosclerotic CVD have become a hot research topic in recent years.…”
Section: Introductionmentioning
confidence: 99%
“…Table 1 provides an overview of studies linking human plaque macrophages with clinical outcome. Total plaque macrophage burden, defined by CD68-positive staining, associates with increased risk of stroke [16] and platelet reactivity [17], whereas associations with stenosis were less clear [18,19].…”
Section: Monocytes and Macrophages In Human Atherosclerosis: Current Statusmentioning
confidence: 99%
“…Macrophages can pass through activated vascular endothelial cells, enter the subendothelial cell space to accumulate, and then proliferate into advanced plaques at the lesion site [ 20 ] (Robbins et al, 2013). The foam cells induce a series of inflammatory responses, resulting in more lipoprotein retention and persistent chronic inflammation, and finally increase the risk of atherosclerosis [ 21 , 22 , 23 ] (Hellings et al, 2008; Libby et al, 2000; Merckelbach et al, 2016).…”
Section: Introductionmentioning
confidence: 99%